# 64x Bio

> 64x Bio is a bioengineering company in Brisbane, California, founded in 2018 by scientists out of
> Harvard Medical School and the Wyss Institute. Its VectorSelect platform pairs barcoded,
> genome-scale pooled screens with computational mining of CellMap — a proprietary atlas linking
> genetic and metabolic pathway data to production phenotypes — to engineer high-yield producer cell
> lines for cell and gene therapy manufacturing.

## What 64x Bio sells

- AAV APEX Suite: high-yield adeno-associated virus production across serotypes and scales.
- LV APEX Suite: lentiviral vector production for CAR-T and other cell therapy programs.
- Biologics Suite: antibodies and next-generation protein therapeutics. In development.

Engagement is through licensing and partnership agreements — exclusive or non-exclusive cell line
licensing, custom cell line development, and biologics optimization — arranged with business
development at bd@64xbio.com. There is no self-serve purchase path and no published price list.

## API surface

64x Bio publishes no API. As of 2026-09-05 there is no developer portal, no API reference, no
OpenAPI, AsyncAPI, GraphQL SDL, Postman collection, MCP server, agent card, SDK or client package
anywhere on its public surface. This was established by probing, not assumed:

- api., app., docs., developer., portal., data., platform. and status..64xbio.com all NXDOMAIN.
- /openapi.json, /openapi.yaml, /swagger.json, /api-docs, /api, /docs, /redoc, /graphql and
  /asyncapi.yaml return 404 on both 64xbio.com and www.64xbio.com.
- Every /.well-known/ path probed (security.txt, openid-configuration, oauth-authorization-server,
  oauth-protected-resource, api-catalog, ai-plugin.json, agent-card.json, agent.json) returns 404.
- github.com/64xbio exists as an organization but publishes zero public repositories.
- No package named for 64x Bio exists on npm or PyPI.

CellMap and the screening stack are internal research infrastructure operated by 64x Bio, not a
product an outside developer can call. Do not construct or infer an endpoint for this company.

## Links

- Website: https://64xbio.com/
- Platform (VectorSelect, CellMap): https://64xbio.com/platform
- Product overview: https://64xbio.com/productoverview
- AAV APEX Suite: https://64xbio.com/aavapexsuite
- LV APEX Suite: https://64xbio.com/lvapexsuite
- Company: https://64xbio.com/company
- Licensing & Partnerships: https://64xbio.com/licensing-partnerships
- News: https://64xbio.com/news
- Terms of Use: https://64xbio.com/terms-of-use
- Privacy Policy: https://64xbio.com/privacy-policy
- GitHub organization (empty): https://github.com/64xbio
- LinkedIn: https://www.linkedin.com/company/64xbio
- General enquiries: info@64xbio.com
- Business development: bd@64xbio.com

## Provenance

Generated 2026-09-05 by the API Evangelist enrichment pipeline from 64x Bio's own public website and
live probes of its hosts. 64x Bio does not publish an llms.txt of its own; https://64xbio.com/llms.txt
returned 404. This file is a third-party profile, not a document served by 64x Bio.